The enigmatic nature of apocrine breast lesions

Virchows Archiv

Volumn 448, Issue 5, 2006, Pages 525-531

  Zagorianakou, P ^a   Zagorianakou, N ^a   Stefanou, D ^a   Makrydimas, G ^a   Agnantis, N J ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Apocrine carcinoma; Apocrine epithelium; Breast; Fibrocystic changes; GCDFP 15; Molecular alterations

Indexed keywords

GLYCOPROTEIN;

AMNION FLUID; APOCRINE CARCINOMA; APOCRINE GLAND; BREAST ADENOMA; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CYST; BREAST EPITHELIUM; BREAST FIBROADENOMA; BREAST LESION; CANCER CELL CULTURE; CANCER CLASSIFICATION; CANCER GRADING; CANCER RISK; CARCINOMA IN SITU; CELL DIFFERENTIATION; DISEASE MARKER; GENOME ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN GENOME; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MALIGNANT TRANSFORMATION; PREGNANT WOMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TISSUE SECTION; WORLD HEALTH ORGANIZATION;

ANIMALS; APOCRINE GLANDS; BREAST; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; FEMALE; HUMANS;

EID: 33749379635     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-005-0095-z     Document Type: Review

References (97)

1. Abati AD, Kimmel M, Rosen PP (1990) Apocrine mammary carcinoma. A clinicopathologic study of 72 cases. Am J Clin Pathol 94(4):371-377
2. Agnantis NJ, Mahera H, Maounis N, Spandidos DA (1992) Immunohistochemical study of ras and myc oncoproteins in apocrine breast lesions with and without papillomatosis. Eur J Gynaecol Oncol 13:309-331
3. Ahmed A (1975) Apocrine metaplasia in cystic hyperplastic mastopathy. Histochemical and ultrastructural observations. Pathol (Lond) 115:211-214
4. Azzopardi J (1979) Problems in breast pathology. Saunders, Philadelphia, pp 341-344
5. Baddoura FK, Judd RL (1990) Apocrine adenoma of the breast. Report of a case with investigation of lectin binding patterns in apocrine breast lesions. Mod Pathol 3:373-376
6. Belanger A, Caron S, Labrie F et al (1990) Levels of eighteen nonconjugated and conjugated steroids in human breast cysts fluid; relationship with cyst type. Eur J Cancer 26:277-281
7. Boccardo F, Valenti G, Zanardi S, Cerruti G, Fassio T, Bruzzi P, De Francis V, Barreca A, Del Monte P, Minuto F (1988) Epidermal growth factor in breast cyst fluid: relationship with intracystic cation and androgen conjugate content. Cancer Res 45:5860-5863
8. Bruzzi P, Dogliotti L, Naldoni C et al (1997) Cohort study of association risk of breast cancer. BMJ 314:925-928
9. Bryant J (1981) Male breast cancer: a case of apocrine carcinoma with psammoma bodies. Hum Pathol 12:751-753
10. Bussolati G, Sapino A, Gugliotta P, Marci L (1992) Cytological analysis of benign breast disease. Cancer Detect Prev 16:89-92
11. Bundred NJ, West RR, O'Dowd J, Mansel RE (1991) Is there an increased risk of breast cancer in women who have a breast cyst aspirated? Br J Cancer 64:953-955
12. Cancer Committee of the College of American Pathologists (1986) Is 'fibrocystic disease' of the breast precancerous? Arch Pathol Lab Med 110:171-173
13. Carter DJ, Rosen PP (1991) Atypical apocrine metaplasia in sclerosing lesions of the breast: a study of 51 patients. Mod Pathol 4:1-5
14. Castagnetta L, Granata OM, Brignone G, Blasi L, Arcuri F, Mesiti MD, Aquino A, Preitano W (1990) Steroid patterns of benign breast disease. Ann N Y Acad Sci 586:79-82
15. Collett K, Maehle BO, Skjarven R et al (1996) Prognostic role of oestrogen, progesterone and androgen receptor in relation to patient age in patient age in patients with breast cancer. Breast 5:123-126
16. Collette J, Hendrick JC, Jaspar JM, Franchimont P (1986) Presence of alpha-lactalbumin, epidermal growth factor, epithelial membrane antigen, and gross cystic disease fluid protein (15,000 Daltons) in breast cyst fluid. Cancer Res 46(7):3728-3733
17. Constantini M, Bucchi I, Dogliotti et al (1994) Cohort study of women with aspirated gross cysts of the breast: an update in recent developments in the study of benign breast disease. In: Mansel RE (ed) Recent developments in the study of benign breast disease. Parthenon Publishing Group, Manchester, pp 227-240
18. Cotran RS, Kumar V, Robbins SL (1994) Cellular growth and differentiation. In: Robbins SL (ed) Robbins pathologic basis of disease, 5th edn. WB Saunders, Philadelphia, pp 35-50
19. Dawson EK (1932) Sweat gland carcinoma of the breast. A morphohistological study. Edinb Med J 39:409-438
20. Dixon JM, McDonald, Elton RA, Miller WR (1999) Risk of breast cancer in women with palpable breast cysts: a prospective study. Edinburgh Breast Group. Lancet 353:1742-1745
21. Duggan MA, Young GK, Hwang WS (1998) Fine-needle aspiration of an apocrine breast carcinoma with multivacuolated lipid-rich giant cells. Diagn Cytopathol 4:62-66
22. Dupont WD, Page DL (1985) Risk factors for breast cancer in women with proliferative disease. N Engl J Med 312:146-151
23. Durham JR, Fechner RE (2000) The histologic spectrum of apocrine lesions of the breast. Am J Clin Pathol 113:3-18
24. Ellis LM, Wittliff L, Bryant MS et al (1989) Correlation of oestrogen, progesterone and androgen receptors in breast cancer. Am J Surg 157:577-581
25. Eusebi V, Azzopardi JG (1980) Lobular endocrine neoplasia in fibroadenoma of the breast. Histopathology 4:413-428
26. Eusebi V, Betts CM, Haagensen DE, Bussolati G, Azzopardi JG (1984) Apocrine differentiation in lobular carcinoma of the breast. Hum Pathol 15:134-140
27. Eusebi V, Damiani S, Losi L, Millis RR (1997) Apocrine differentiation in breast epithelium. Adv Anat Pathol 4:139-155
28. Frable WJ (1989) Needle aspiration biopsy: past, present, and future. Hum Pathol 20:504-517
29. Frable WJ, Kay S (1968) Carcinoma of the breast. Histologic and clinical features of apocrine tumors. Cancer 21:756-763
30. Gatalica Z (1997) Immunohistochemical analyses of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ. Pathol Res Pract 193:753-758
31. Gilles R, Guinebretiere JM, Toussaint C et al (1994) Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology 191:633-638
32. Gupta RK, Wakefield SJ, Naran S, Dowle CC (1989) Immunocytochemical and ultra-structural diagnosis of a rare mixed apocrine-medullary carcinoma of the breast in a fine needle aspirate. Acta Cytol 33:104-108
33. Haagensen DE Jr, Mazoujian G (1996) In: Haagenson, CD (ed) Diseases of the breast, 3rd edn. WB Saunders, Philadelphia, pp 474-500
34. Haagensen DE Jr, Gall SA, Brazy JE, Giannola J, Wells SA Jr (1980) Analysis of amniotic fluid, maternal plasma, and cord blood for a human breast gross cystic disease fluid protein. Am J Obstet Gynecol 138(1):25-32
35. Haagensen CD, Bodian C, Haagensen DE Jr (1981) Apocrine epithelium. Breast carcinoma, WB Saunders, Philadelphia pp 83-105
36. Haagensen DE, Dilley WG, Mazoujian G et al (1990) Review of GCDFP-15: an apocrine marker protein. Ann N Y Acad Sci 586:161-173
37. Higginson JF, McDonald JR (1949) Apocrine tissue, chronic cystic mastitis and sweat gland carcinoma of the breast. Surg Gynecol Obstet 88:1-10
38. Howard BA, Gusterson BA (2000) Human breast development. J Mammary Gland Biol Neoplasia 5(2):119-137
39. Izuo M, Okagaki T, Richart R, Lattes R (1971) DNA content in 'apocrine metaplasia'of fibrocystic disease of the breast. Cancer 27:643-650
40. Jones C, Damiani S, Wells D, Chaggar R, Lakhani SR, Eusebi V (2001) Molecular cytogenetic comparison of apocrine hyperplasia and apocrine carcinoma of the breast. Am J Pathol 158:207-214
41. Kaya H, Aribal E, Yegen C (2002) Apocrine differentiation in invasive pleomorphic lobular carcinoma with in situ ductal and lobular apocrine carcinoma: case report. Pathol Oncol Res 8 (2):151-152
42. Kline TS (1988) Handbook of fine needle aspiration biopsy cytology. CV Mosby, St. Louis
43. Kuenen-Boumeester V, Van der Kwast TH, van Putten WL, Claasen C, van Ooijen B, Henzen-Longmans SC (1992) Immunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancer. Int J Cancer 52:581-584
44. Lakhani SR, Slack DN, Hamoudi RAA, Collins N, Stratton MR, Sloane JP (1996) Detection of allelic imbalance indicates that a proportion of mammary hyperplasia of usual type is clonal, neoplastic proliferations. Lab Invest 74:129-135
45. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D et al (2001) Initial sequencing and analysis of the human genome. Nature 409:860-921
46. Lininger RA, Tavassoli FA (1997) Atypical intraductal hyperplasia of the breast. In: Silverstein MJ (ed) Ductal carcinoma in situ of the breast, Williams & Wilkins, Baltimore, pp 195-222
47. Lodato RF, Maguire HC Jr, Greene MI, Weiner DB, LiVolsi VA (1990) Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast. Mod Pathol 3(4):449-454
48. Losi L, Lorenzini R, Eusebi V, Bussolati G (1995) Apocrine differentiation in invasive carcinoma of the breast. Comparison of monoclonal and polyclonal gross cystic disease fluid protein-15 antibodies with prolactin-inducible protein mRNA gene expression. Appl Immunohistochem 3:91-98
49. Love SM, Gelman RS, Silen W (1982 Oct 14) Sounding board. Fibrocystic Disease of the breast - a non disease? N Engl J Med 307(16):1010-1014
50. Matsuo K, Fukutomi T, Hasegawa T, Akashi-Tanaka S, Nanasawa T, Tsuda H (2002) Histological and immunohistochemical analysis of apocrine breast carcinoma. Breast Cancer 9:43-49
51. McKiernan O, Coyne J, Cahalane S (1988) Histology of breast development in early life. Arch Dis Child 63:136-139
52. Miller WR, Forrest APM (1983) Androgen conjugates in human breast secretions and cyst fluids. In: Angeli A, Bradlow HL, Dogliotti L (eds) Endocrinology of cystic disease. Raven Press, New York, pp 77-84
53. Moriya T, Sakamoto K, Sasano H, Kawanaka M, Sonoo H, Manabe T, Ito J (2000) Immunohistochemical analysis of Ki-67, p53, p21 and p27 in benign and malignant apocrine lesions of the breast: its correlation to histologic findings in 43 cases. Mod Pathol 13:13-18
54. Mossler JA, Barton TK, Brinkhous AD et al (2005) Apocrine differentiation in human mammary carcinoma. Cancer 46:2463-2471
55. Moinfar F, Okcu M, Tsybrovskyy O et al (2003) Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies. Cancer 9:335-336
56. Murad TM, von Hamm E (1968) The ultrastructure of fibrocystic disease of the breast. Cancer 22:587-600
57. Murphy LC, Lee-Wing M, Goldenberg GJ, Shiu RPC (1987) Cancer Res 47:4160-4164
58. O'Malley FP, Page DL, Nelson EH, Dupont WD (1994) Ductal carcinoma in situ of the breast with apocrine cytology: definition of a borderline category. Hum Pathol 25:164-168
59. Pagani A, Sapino A, Eusebi V, Bergnolo P, Bussolati G (1994) PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast. Virchows Arch 425:459-465
60. Page DL, Van der Zwaar R, Rogers LW, Williams LT, Walker WE, Hartmann WH (1978) Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst 61:1055-1063
61. Page DL, Dupont WD, Jensen RA (1996) Papillary apocrine change of the breast: association with atypical hyperplasia and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 5:29-32
62. Papamichalis G, Francia K, Karachaliou FE, Anastasiades OT, Spandidos DA (1988) Expression of the c-myc oncoprotein in human metaplastic epithelial cells of fibrocystic disease. Anti-cancer Res 8:1217-1222
63. Papanicolaou GN (1963) Atlas of exfoliative cytology. Harvard University Press, Cambridge, p 55
64. Papotti M, Eusebi V, Gugliotta P et al (1983) Immunohistochemical analysis of benign and malignant papillary lesions of the breast. Am J Surg Pathol 7:451-461
65. Pier WJ, Garancis JC, Kuzma JF (1970) The ultrastructure of apocrine cells in intracystic papilloma and fibrocystic disease of the breast. Arch Pathol 89:446-452
66. Raju U, Zarbo RJ, Kubus J et al (1993) The histologic spectrum of apocrine breast proliferations: a comparative study of morphology and DNA content by image analysis. Hum Pathol 24:173-181
67. Rosai J (1996) Ackerman's surgical pathology, 8th edn. CV Mosby, St. Louis, pp1582-1583
68. Roberts MM, Jones V, Elton RA et al (1984) Risk of breast cancer in women with a history of benign disease of the breast. BMJ 288:275-278
69. Rosen PP (2001) Rosen's Breast Pathology, 2nd edn. Lippincott Williams & Wilkins, Philadelphia
70. Russo J, Russo IH (2004) Development of the human breast. Maturitas 24;49(1):2-15
71. Sapp M, Malik A, Hanna W (2003) Hormone receptor profile of apocrine lesions of the breast. Breast J 9:335-336
72. Selim AG, Wells CA (1999) Immunohistochemical localization of androgen receptor in apocrine metaplasia and apocrine adenosis of the breast: relation to oestrogen and progesterone receptors. J Clin Pathol 52:838-841
73. Selim AG, Ryan A, El-Ayat G, Wells CA (2001) Loss of heterozygosity and allelic imbalance in apocrine adenosis of the breast. Cancer Detect Prev 25:262-267
74. Selim AGA, El-Ayat, Wells CA (2002) Expression of c-erbB2, p53, Bcl-2, Bax, c-myc and Ki-67 in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast. Virchows Arch 441:449-455
75. Selim AG, Ryan A, El-Ayat G, Wells CA (2002) Loss of heterozygosity and allelic imbalance in apocrine metaplasia of the breast: microdissection microsatellite analysis. J Pathol 196:287-291
76. Seidman JD, Ashton M, Lefkowitz M (1996) Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow up. Cancer 77:2529-2537
77. Shiu RPC, Iwasiow BM (1985) Prolactin inducible proteins in human breast cancer cells. J Biol Chem 260:11307-11313
78. Silverberg SG, Masood S (1997) The breast. In: Silverberg SG, Delellis RA, Frable WJ (eds) Principles and practice of surgical pathology and cytopathology, 3rd edn. Churchill Livingstone, New York, pp 575-674
79. Simpson JF, Page DL, Dupont WD (1990) Apocrine adenosis - a mimic of mammary carcinoma. Surg Pathol 3:289-299
80. Simpson PT, Reis-Fihlo JS, Gale T, Lakhani S (2005) Molecular evolution of breast cancer. J Pathol 205:248-254
81. Sternberg SS (1997) Histology for pathologists, 2nd edn. Lippincott-Raven, Philadelphia, p 26
82. Tashiro T, Hirokawa M, Iuchi K, Emoto K, Tanaka T, Monobe Y, Sano T (2003) Cytology of pleomorphic lobular carcinoma with apocrine cell differentiation of the breast. A case report. Acta Cytol 47(2):265-269
83. Tavassoli FA, Norris HJ (1994) Intraductal apocrine carcinoma: a clinicopathologic study of 37 cases. Mod Pathol 7:813-818
84. Tavassoli F, Devilee P (2003) Pathology and genetics of tumors of the breast and female genital organs. IARC Press, Lyon, p 10
85. The Consensus Conference Committee (1997) Consensus conference on the classification of ductal carcinoma in situ. Cancer 80:1798-1802
86. Tremblay G (1968) Histochemical studies of oxidative enzymes in apocrine like cells of the breast and in axillary apocrine glands. J Invest Dermatol 50:238-243
87. Tsuda H, Fukutomi T, Hirohashi S (1995) Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade. Clin Cancer Res 1:261-267
88. Vasiu R, Olinici CD (1990) DNA nuclear content of apocrine cells in fibrocystic mastopathy and breast cancer. Morphol Embryol 36:43-47
89. Viacava P, Naccarato AG, Bevilaqua G (1997) Apocrine epithelium of the breast: does it result from metaplasia? Virchows Arch 431:205-2090
90. Washington C, Dalbegue F, Abreo F, Taubenberger JK, Lichy JH (2000) Loss of heterozygosity in fibrocystic change of the breast: genetic relationship between benign proliferative lesions and associated carcinomas. Am J Pathol 157:323-329
91. Wellings SR, Alpers CE (1987) Apocrine cystic metaplasia: subgross pathology and prevalence in cancer-associated versus random autopsy breasts. Hum Pathol 18:381-386
92. Wellings SR, Jensen HM, Marcum RG (1975) An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 55:231-243
93. Wells CA, McGregor IL, Makunura CN, Yeomans P, Davies JD (1995) Apocrine adenosis: a precursor of aggressive breast cancer? J Clin Pathol 48:737-742
94. Wick MR, Lillemoe TJ, Copland GT, Swanson PE, Manivel JC, Kiang DT (1989) Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with a-lactalbumin. Hum Pathol 20:281-287
95. Yoshida K, Inone M, Furuta S, Sakai R, Imai R, Hayakawa S, Fukatsu T, Nagasaka T, Nakashima N (1996) Apocrine carcinoma versus Apocrine metaplasia with atypia of the breast. Use of aspiration biopsy cytology. Acta Cytol 40(2):247-251
96. Zajdela A, Ghossein NA, Pilleran JP et al (1975) The experience of aspiration cytology in the diagnosis of breast cancer. Experience at the Fondation Curie. Cancer 35:499-506
97. Zoran G (1997) Immunohistochemical analysis of apocrine breast lesions: consistent overexpression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine in situ. Pathol Res Pract 193:753-758